Search

Search Results

• 

  Granulomatosis with polyangiitis in Tunisia

  I. Ben Ghorbel, N. Belfeki, N. Baouendi, T. Ben Salem, M.H. Houman

  23-29

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.935

  1880

  PDF: 844
• 

  Perivascular fibrosis and IgG4-related disease: a case report

  S. Monti, G. Crepaldi, A. Peri, A. Pietrabissa, P. Morbini, F. Bobbio-Pallavicini, C. Montecucco, R. Caporali

  245-248

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.753

  2225

  PDF: 1133

• PO:02:030 | Retention Rate of Non-anti-TNF Therapies and primary failure in monocentric cohort of patients with Psoriatic Arthritis Alba Chiara Pozzi¹, Sofia Barezzani², Andrea Galli², Cesare Tomasi¹, Micol Frassi¹, Ilaria Cavazzana¹, Franco Franceschini¹ | ¹Rheumatology and Clinical Immunology Unit ERN-ReCONNECT, ASST Spedali Civili, University of Brescia Brescia, Italy; ²Facoltà di Medicina e Chirurgia, University of Brescia Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2288

  22

• Efficacy of Cellfood®’s therapy (deutrosulfazyme) in fibromyalgia

  M.E. Nieddu, L. Menza, F. Baldi, B. Frediani, R. marcolongo

  316-321

  https://doi.org/10.4081/reumatismo.2007.316

  2664

  PDF: 1709
• 

  Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

  J. Mencarini, M. Spinicci, F. Bartalesi

  144-147

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.897

  2275

  PDF: 1227
• 

  Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids

  S. Parisi, M. Bruzzone, C. Centanaro Di Vittorio, A. Laganà, C.L. Peroni, E. Fusaro

  286-291

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.691

  2913

  PDF: 1322
• 

  Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

  R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

  83-89

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.875

  2067

  PDF: 1003

  IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 616

• PO:34:217 | Possible role of phosphodiesterase type 5 inhibitors in the prevention of digital ulcers and videocapillaroscopic changes in patients with systemic sclerosis Elena Platania¹, Marius Cadar¹, Ilaria Bisconti¹, Davide Mohammad Reza Beigi^1|2, Francesca Romana Di Ciommo¹, Jacopo Landro¹, Martina Salerno¹, Beatrice De Girolamo¹, Simona Truglia¹, Fabrizio Conti¹, Valeria Riccieri¹ | ¹S.C. Reumatologia; ²S.C. Reumatologia

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2214

  177

• PO:28:128 | Rheumatic fever: an atypical case Giovanni Italiano¹, Melania Coscia¹, Arianna Monteforte¹ | ¹AORN S. Anna e S. Sebastiano Caserta, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2359

  35

• Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

  Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

  31-38

  https://doi.org/10.4081/reumatismo.2006.31

  1912

  PDF: 2619
• 

  Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue

  T Aizan Izzati Binti T Mohd Yatim, Chiew Gek Khor, Eu Ping Poh

  21-04-2026

  https://doi.org/10.4081/reumatismo.2026.1826

  308

  PDF: 74

• Long-term effects of cyclic therapy with iloprost in systemic sclerosis

  M. Scarsi, M. Rossi, E. Danieli, A. Frigè, A. Grottolo, A. Zambruni, P. Airò

  114-119

  https://doi.org/10.4081/reumatismo.2008.114

  978

  PDF: 948
• 

  Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide

  M. Benucci, F. Li Gobbi, P. Panconesi, M. Manfredi, P. Sarzi-Puttini, F. Atzeni

  90-94

  27-05-2013

  https://doi.org/10.4081/reumatismo.2013.90

  2672

  PDF: 971

• PO:14:199 | Preliminary data of a multicentric study on safety and efficacy of assisted reproductive techniques in pregnant women with systemic autoimmune diseases Valentina Canti¹, Maria Bernadette Cilona¹, Giuditta Gorgone¹, Federica Pasi¹, Antonia Calligaro², Francesca Ruffilli³, Francesca Crisafulli⁶, Maria Tonello², Eleonora Giacobbe⁴, Alba Chiara Pozzi⁶, Maria Chiara Gerardi⁴, Melissa Padovan³, Emanuele Bizzi⁵, Enrico Papaleo¹, Beatrice Maranini³, Marcello Govoni³, Massimiliano Epis⁴, Angela Tincani⁶, Andrea Doria², Patrizia Rovere Querini¹ | ¹IRCCS Ospedale San Raffaele and VitaSalute San Raffaele Milano, Italy; ²Rheumatology Unit, Departement of Medicine, University Hospital of Padua Padova, Italy; ³Rheumatology Unit, Azienda Ospedaliero Universitaria S. Anna Ferrara, Department of Medical Sciences, University of Fe Ferrara, Italy; ⁴ASST Grande Ospedale Metropolitano Niguarda Milano, Italy; ⁵Internal Medicine, Fatebenefratelli Hospital Milano, Italy; ⁶Rheumatology and Immunology Unit, ASST Spedali Civili Brescia e Università degli Studi di Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2322

  26

• Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment

  Ombretta Di Munno, Andrea Delle Sedie

  11-21

  https://doi.org/10.4081/reumatismo.2006.11

  1247

  PDF: 1635
• 

  Pain in Sjögren’s syndrome

  C. Giacomelli, R. Talarico, C. Baldini, L. Bazzichi

  39-43

  06-06-2014

  https://doi.org/10.4081/reumatismo.2014.763

  2654

  PDF: 1525

• PO:20:011 | Suspected tumor-induced osteomalacia in a patient with polymyalgia rheumatica and persistent hyperphosphaturic hypophosphatemia Andrea Faggiano^1|2, Francesco Goatelli^1|2, Lucia Dardani², Carlo Salvarani³ | ¹Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area Jonica, University of Bari; ²Scuola di Specializzaione in Reumatologia, Università degli Studi di Modena e Reggio Emilia, Modena, Italy; ³Direttore SOC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL REGGIO EMILIA, Italy  

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2176

  163

• PO:35:223 | Biologic therapy for sustained remission in eosinophilic myocarditis: real-world evidence from a tertiary center experience Federica Davanzo¹, Caterina Menghi², Andrea Silvio Giordani², Anna Baritussio², Federico Scognamiglio², Cristina Vicenzetto², Luca Iorio¹, Renzo Marcolongo², Cristina Basso³, Andrea Doria¹, Roberto Padoan¹, Alida Linda Patr Caforio² | ¹Rheumatology Unit, Department of Medicine, University of Padua Padova, Italy; ²Cardiology Unit, Department of Cardiac, Vascular, Thoracic Sciences and Public Health, University of Padua Padova, Italy; ³Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2383

  28

• CO:12:1 | Inside the Heterogeneity of Primary Central Nervous System Vasculitis: A single-centre 40-year experience Carlo Salvarani¹, Gene G Hunder², Caterina Giannini², Teresa Jh Christianson², Robert D Brown² | ¹Azienda USL-IRCCS di Reggio Emilia e UNIMORE Reggio Emilia, Italy; ²Mayo Clinic Rochester, USA

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2279

  18

• PO:14:202 | Use of anifrolumab in the treatment of the hematological manifestations of systemic lupus erythematosus: a single-centre case series Gaia Ferracane^1|2, Jessika Dichiara^1|2, Elena Manna^1|2, Lorenzo Mattia Bianchessi^1|2, Giovanni Zanframundo^1|2, Serena Bugatti^1|2, Veronica Codullo^1|2, Lorenzo Cavagna^1|2, Francesca Bottazzi^1|2 | ¹Department of Internal Medicine and Therapeutics, Università di Pavia; ²Division of Rheumatology, IRCCS Policlinico San Matteo, Pavia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2159

  209
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  4173

  PDF: 699
• 

  Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients

  F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula

  97-102

  09-02-2016

  https://doi.org/10.4081/reumatismo.2015.829

  2500

  PDF: 1387

• PO:33:201 | Metabolic and functional state of circulating platelets in patients with systemic sclerosis Annalisa Villa¹, Simona Truglia¹, Francesca Maiorca², Annamaria Sabetta², Ludovica Lombardi², Silvia D'Orso², Lucia Stefanini², Fabrizio Conti¹, Marcella Visentini², Valeria Riccieri¹ | ¹Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Università degli Studi di Roma La Sapienza; ²Dipartimento di Medicina Traslazionale e di Precisione, Università degli Studi di Roma La Sapienza

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2209

  137

• Frequency of the bleeding risk in patients receiving warfarin submitted to arthrocentesis of the knee

  G. Salvati, L. Punzi, M. Pianon, C. Valvason, F. Schiavon, N. Noal, S. Todesco

  159-163

  https://doi.org/10.4081/reumatismo.2003.159

  2054

  PDF: 2007

• PO:05:074 | A clinical case of a patient affected by long-standing psoriatic arthritis and multiple comorbidities treated with an anti-IL-23 therapy Maria Letizia Currò¹, Angelo Tropea¹, Alessandra Burgio¹, Francesca Cracò¹, Antonio Pezzano¹, Federica Rapisarda¹, Antonino Palumbo¹, Valeria D'Amico¹, Fabiola Atzeni¹ | ¹Clinica Reumatologica di Udine, Dipartimento di Medicina, ASUFC, Udine, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2133

  140

• Sodium-gold thyosolphatum therapy: an open, viewed, multicenter trial in rheumatoid arthritis patients followed for two years

  M.L. Ciompi, C. Amoresano, P. Balzarini, L.M. Bazzichi, M. Broggini, L. Buratti, F. Calcagnile, A. Ciocci, S. Ferri, C. Fichera, M. Fumagalli, M. Muratore, F. Nitti, G. Peruz, G. Romagnoni

  251-256

  https://doi.org/10.4081/reumatismo.2002.251

  1003

  PDF: 1392

• PO:18:277 | Clinical case report of the management of a patient suffering from systemic lupus erythematosus and associated polyneuropathy Davide Murgia¹, Elena Marazzi¹, Rosetta Vitetta¹, Guido Rovera¹. | ¹ASLVC SSD reumatologia, Ospedale sant'Andrea Vercelli, Vercelli, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2048

  150
• 

  Successful treatment of refractory adult onset Still’s disease with rituximab

  N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

  159-162

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.888

  2905

  PDF: 1367
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.155

  2640

  PDF: 1685

• PO:10:155 | Etanercept-induced lupus in a patient with rheumatoid arthritis: diagnostic challenges and multidisciplinary therapeutic approach Camilla Riboldi^1|2, Claudia Iannone^1|2, Maria Gerosa^1|2, Roberto Felice Caporali^1|2 | ¹ASST G. Pini-CTO, U.O.C. di Clinica Reumatologica, Milano; ²Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2149

  147

• Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience

  F. Giorgetti, M.L. Minnucci, P. Santori, L. Ercoli, M. Rossi, M. Del Papa, G. Morico, P. Squadroni, A. Olivieri, R. Centurioni

  51-56

  https://doi.org/10.4081/reumatismo.2004.51

  1302

  PDF: 1188

• PO:22:032 | Beyond the joints: a rare case of subcorneal pustular dermatosis in Rheumatoid Arthritis Sara Casella^1|2, Carlo Smirne^1|2, Roberta Zaira Pedrazzoli³, Mattia Perazzi^1|3, Edoardo Cammarata⁴, Francesca Zottarelli⁴, Paola Savoia⁵, Renzo Boldorini⁶, Mario Pirisi^1|2, Pier Paolo Sainaghi^1|3 | ¹Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale Novara, Italy; ²Unità di Medicina Interna, Azienda Ospedaliera Maggiore della Carità Novara, Italy; ³Unità di Medicina Interna e Reumatologia, Azienda Ospedaliera Maggiore della Carità Novara, Italy; ⁴Unità di Dermatologia, Azienda Ospedaliera Maggiore della Carità Novara, Italy; ⁵Dipartimento di Scienze della salute, Università del Piemonte Orientale Novara, Italy; ⁶Unità di Anatomia Patologica, Azienda Ospedaliera Maggiore della Carità Novara, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2345

  42

• Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a sistematic review

  F. Capsoni

  6-13

  https://doi.org/10.4081/reumatismo.2008.6

  1513

  PDF: 958

• PO:22:033 | Unraveling VEXAS syndrome: when skin manifestations and monoclonal gammopathy precede hematological myeloid alterations Laura Di Centa¹, Simone Longhino¹, Valeria Manfrè¹, Stefania Sacco¹, Luca Quartuccio¹ | ¹ASST Papa Giovanni XXIII, Bergamo, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2182

  160
• 

  Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

  M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1544

  1416

  PDF: 769

• PO:11:165 | Clinical mimicry and therapeutic challenge: A Case of Rapidly Progressive Mixed Connective Tissue Disease Elena Maria Di Virgilio¹, Elisabetta Chessa², Valentina Ibba², Cosimina Matulli², Jessica Sorgia¹, Andrea Pace¹, Matteo Piga^1|2, Alberto Cauli^1|2 | ¹Università degli studi di Cagliari-Reumatologia, Cagliari, Italy; ²Struttura complessa di Reumatologia- AOU Cagliari, Cagliari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2311

  45

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  https://doi.org/10.4081/reumatismo.2006.233

  1129

  PDF: 1065
• 

  The role of the general practitioner and the out-of-hospital public rheumatologist in the diagnosis and follow-up of patients with polymyalgia rheumatica

  A. Sobrero, C. Manzo, A. Stimamiglio

  44-50

  27-03-2018

  https://doi.org/10.4081/reumatismo.2018.1036

  2781

  PDF: 1442

• Biologic therapy with anti-TNFa in rheumathoid atrhritis

  G. Ferraccioli

  17-21

  https://doi.org/10.4081/reumatismo.2005.4s.17

  866

  PDF: 742

• PO:11:171 | Subcutaneous tocilizumab use in a young-onset mixed connective tissue disease patient with multiple treatment failures Rhaysa Araujo Mousinho¹, Elide Lupi², Massimiliano Limonta² | ¹Clinica di Reumatologia, Dipartimento di Medicina and ²Istituto di Anatomia Patologica, Dipartimento di Medicina di Laboratorio, Osp. S. M. della Misericordia, Università di Udine, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2154

  153
• 

  Primary Sjögren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies

  E. Shahi, C. Donati, M. Gattinara, I. Pontikaki, V. Gerloni

  97-100

  https://doi.org/10.4081/reumatismo.2011.97

  1602

  PDF: 969

• Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab

  Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare

  59-61

  https://doi.org/10.4081/reumatismo.2006.59

  1042

  PDF: 971

• PO:07:108 | Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study Enrico Marchetta¹, Andrew Östör^2|8, Eugen Feist³, Prodromos Sidiropoulos⁴, Jérôme Avouac⁵, Martin Rebella^6|7, Rajaie Namas⁹, Erin Mcdearmon Blondell¹⁰, Ivan Lagunes¹⁰, Tianming Gao¹⁰, Tim Shaw¹⁰, Suzan Attar¹¹ | ¹AbbVie Srl Roma, Italy; ²Monash University and Emeritus Research, Melbourne, Victoria, Melbourne, Australia; ³Helios Department of Rheumatology and Clinical Immunology, Vogelsang-Gommern, Vogelsang Gommern, Germany; ⁴Faculty of Medicine, University of Crete, Heraklion, Heraklion, Greece; ⁵Service de Rhumatologie, Hôpital Cochin, AP HP Centre Université Paris Cité, Parigi, France; ⁶Departamento de Medicina, Facultad de Medicina, Universidad de la República, Montevideo, Montevideo, Uruguay; ⁷Unidad de Enfermedades Autoinmunes Sistémicas, MUCAM, Montevideo, Montevideo, Uruguay; ⁸Australian National University, Camberra, Australia; ⁹Medical Subspecialties Institute, Division of Rheumatology, Cleveland Clinic Abu Dhabi, United Arab Emirates; ¹⁰AbbVie Inc., North Chicago, Illinois, United States of America Chicago, USA; ¹¹King Abdulaziz University, Jeddah, Saudi Arabia

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2306

  28

• A short history of anti-rheumatic therapy. I. An introduction on traditional and drug treatments

  G. Pasero, P. Marson

  76-83

  https://doi.org/10.4081/reumatismo.2010.76

  1743

  PDF: 1069

• Efficacy of immunosoppressive therapy and steroid sparing effect in interstitial lung disease associated to antisynthetase syndrome

  N. Franzolini, L. Quartuccio, G. De Marchi, S. De Vita

  202-208

  https://doi.org/10.4081/reumatismo.2007.202

  1512

  PDF: 1323

• PO:38:278 | Cognitive behavioural therapy vs. physical therapy for chronic primary low back pain: a systematic review with meta-analysis of randomised controlled trials Luca Castioni¹, Stefano Salvioli² | ¹Università degli studi di Ferrara; ²Scuola di fisioterapia Claudiana, Bolzano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2223

  159
• 

  Anti-N-methyl-d-aspartate receptor encephalitis: mimicker of lupus and multiple sclerosis

  N. Sanghavi, B. Ayesha

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1598

  1866

  PDF: 604

• Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases

  H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi

  299-303

  https://doi.org/10.4081/reumatismo.2007.299

  1048

  PDF: 809

• Cross-cultural adaptation, reliability, and validity of the Turkish version of the Exercise Therapy Burden Questionnaire for individuals with chronic diseases

  F. Sari, S. Sari

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1684

  2375

  PDF: 748

  SUPPLEMENTARY MATERIAL: 354
• 

  Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

  N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

  93-102

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1235

  1210

  PDF: 776